Advertisement
Advertisement

RANI

RANI logo

Rani Therapeutics Holdings Inc Class A

1.40
USD
+0.095
+7.31%
Dec 20, 15:39 UTC -5
Closed
...

Rani Therapeutics Holdings Inc Class A Profile

About

Rani Therapeutics Holdings Inc. is a clinical stage biotherapeutics company. It focused on advancing technologies to enable the development of orally administered biologics. Rani Therapeutics Holdings Inc. is based in SAN JOSE, Calif.

Info & Links

CEO

Talat Imran

Headquarters

2051 RINGWOOD AVENUE
SAN JOSE, CA 95131, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

158

Employees

140

Rani Therapeutics Holdings Inc Class A Statistics

Valuation Measures

Market Capitalization2

114.58M

Enterprise Value

138.61M

Enterprise Value/EBITDA(ttm)

-2.67

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

12.14

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-219.64%

Return on Invested Capital(ttm)

-194.50%

Return on Assets(ttm)

-56.71%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-51.97M

Net Income Available to Common(ttm)

-28.17M

Diluted EPS(ttm)

-1.06

Share Statistics

Beta (5Y Monthly)

0.05

52-Week Change

-44.86%

S&P 500 52-Week Change

24.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

57.29M

Dividend Yield

0.00%

Float4

26.75M

% Held by Insiders

53.30%

% Held by Institutions

30.19%

Balance Sheet

Total Cash(mrq)

30.40M

Total Cash Per Share(mrq)

0.53

Total Debt(mrq)

28.30M

Total Debt/Equity(mrq)

490.13%

Current Ratio(mrq)

1.60%

Quick Ratio(mrq)

1.60%

Book Value Per Share(mrq)

0.11

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.93

Free Cash Flow(ytd)

-27.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement